Boston-based venture fund investing in life sciences, biotech, and A.I. to transform neurological health. Unlocking human potential.
Location
Boston, MA, US
Founded
2018
Drads Capital is a Boston-based venture fund focusing on life sciences, biotechnology, and A.I. companies. They invest in transformative ideas that extend the boundaries of biomedical sciences, particularly in the areas of neurodegenerative disease treatment and mind-body wellness. Their investment strategy targets companies at various stages, from seed to Series C rounds.
The firm's portfolio includes notable companies such as Amylyx Pharmaceuticals, Aztherapies, MarvelBiome, and The Live Green Co. Drads Capital's unique approach involves merging breakthrough science and technology from top academic laboratories and hospitals with strong leadership teams. They aim to invest in brilliant people and innovative ideas that contribute to a healthier future, including advancements in organ regeneration and precision fermentation for food production.
Drads Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
